Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.91
+1.86%
Mkt Cap $458.47M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+236.6%
Consensus $6.43 vs current $1.91
NASDAQ·Healthcare·Biotechnology
$1.91
+1.86%
Mkt Cap $458.47M
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+236.6%
Consensus $6.43 vs current $1.91